- Home
- LXEH vs PYPD Comparison
LXEH vs PYPD Comparison
Compare LXEH & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEH
- PYPD
- Stock Information
- Founded
- LXEH 2001
- PYPD 2008
- Country
- LXEH China
- PYPD Israel
- Employees
- LXEH N/A
- PYPD N/A
- Industry
- LXEH Other Consumer Services
- PYPD Medical/Dental Instruments
- Sector
- LXEH Real Estate
- PYPD Health Care
- Exchange
- LXEH Nasdaq
- PYPD Nasdaq
- Market Cap
- LXEH 25.1M
- PYPD 26.7M
- IPO Year
- LXEH 2020
- PYPD 2020
- Fundamental
- Price
- LXEH $1.86
- PYPD $3.27
- Analyst Decision
- LXEH
- PYPD Strong Buy
- Analyst Count
- LXEH 0
- PYPD 4
- Target Price
- LXEH N/A
- PYPD $10.25
- AVG Volume (30 Days)
- LXEH 304.7K
- PYPD 72.8K
- Earning Date
- LXEH 06-17-2025
- PYPD 05-14-2025
- Dividend Yield
- LXEH N/A
- PYPD N/A
- EPS Growth
- LXEH N/A
- PYPD N/A
- EPS
- LXEH N/A
- PYPD N/A
- Revenue
- LXEH $4,493,795.00
- PYPD N/A
- Revenue This Year
- LXEH N/A
- PYPD N/A
- Revenue Next Year
- LXEH N/A
- PYPD N/A
- P/E Ratio
- LXEH N/A
- PYPD N/A
- Revenue Growth
- LXEH N/A
- PYPD N/A
- 52 Week Low
- LXEH $1.53
- PYPD $2.30
- 52 Week High
- LXEH $50.08
- PYPD $4.49
- Technical
- Relative Strength Index (RSI)
- LXEH 33.60
- PYPD 64.41
- Support Level
- LXEH $1.91
- PYPD $2.98
- Resistance Level
- LXEH $2.10
- PYPD $3.30
- Average True Range (ATR)
- LXEH 0.25
- PYPD 0.24
- MACD
- LXEH 0.37
- PYPD 0.05
- Stochastic Oscillator
- LXEH 22.41
- PYPD 95.40
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.